Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol

INTRODUCTION: Cachexia is common in malignant mesothelioma (MM); half of patients have malnutrition and low skeletal muscle mass. Malnourished patients have worse quality of life (QoL). Weight loss is strongly associated with poor survival. Anamorelin is an oral ghrelin receptor agonist that improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoon, Siao Nge, Fyfe, Katrina, Peddle-McIntyre, Carolyn J, Bowyer, Samantha, Hawkins, Felicity, Jeffery, Emily, Chih, Hui Jun, Creaney, Jenette, Nowak, Anna, Brims, Fraser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Pleural Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173983/
https://www.ncbi.nlm.nih.gov/pubmed/32213537
http://dx.doi.org/10.1136/bmjresp-2019-000551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173983/
https://www.ncbi.nlm.nih.gov/pubmed/32213537
http://dx.doi.org/10.1136/bmjresp-2019-000551

Ejemplares similares